Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4,4'-oxybis-2-butanol
2. 4,4'-oxydi-2-butanol, 2-(14)c-labeled
3. Debutil
4. Dhdbe
5. Dihydroxybutyl Ether
6. Dihydroxydibutylether
7. Dis-cinil
1. Dyskinebyl
2. 821-33-0
3. Diskin
4. 2-butanol, 4,4'-oxybis-
5. Colenormol
6. Oxydibutanol
7. Discinil
8. 4-(3-hydroxybutoxy)butan-2-ol
9. Dihydroxydibutylether
10. Cr6x2y7nrr
11. Bis(3-hydroxybutyl) Ether
12. 4,4'-oxybis(butan-2-ol)
13. 4,4'-oxybisbutan-2-ol
14. Boutybil
15. 5-oxa-2,8-nonandiol
16. Unii-cr6x2y7nrr
17. 2-butanol, 4,4'-oxydi-
18. Hydroxybutyloxide
19. Einecs 212-475-3
20. 1,1'-dimethyl-3,3'-oxydipropanol
21. Dis-cinil
22. Schembl620600
23. Dtxsid70870777
24. Chebi:134793
25. Hydroxybutyloxide [who-dd]
26. Dhbe (dihydroxydibutylether)
27. 4,4'-oxydi-2-butanol [mi]
28. Db14079
29. Q27275685
| Molecular Weight | 162.23 g/mol |
|---|---|
| Molecular Formula | C8H18O3 |
| XLogP3 | 0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 6 |
| Exact Mass | 162.125594432 g/mol |
| Monoisotopic Mass | 162.125594432 g/mol |
| Topological Polar Surface Area | 49.7 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 75.4 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Film Formers & Plasticizers
Taste Masking
Coating Systems & Additives
Fillers, Diluents & Binders
Parenteral
Chewable & Orodispersible Aids
Direct Compression
Co-Processed Excipients
Soft Gelatin
ABOUT THIS PAGE
A dihydroxydibutyl ether manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of dihydroxydibutyl ether, including repackagers and relabelers. The FDA regulates dihydroxydibutyl ether manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. dihydroxydibutyl ether API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A dihydroxydibutyl ether supplier is an individual or a company that provides dihydroxydibutyl ether active pharmaceutical ingredient (API) or dihydroxydibutyl ether finished formulations upon request. The dihydroxydibutyl ether suppliers may include dihydroxydibutyl ether API manufacturers, exporters, distributors and traders.
dihydroxydibutyl ether Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of dihydroxydibutyl ether GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right dihydroxydibutyl ether GMP manufacturer or dihydroxydibutyl ether GMP API supplier for your needs.
A dihydroxydibutyl ether CoA (Certificate of Analysis) is a formal document that attests to dihydroxydibutyl ether's compliance with dihydroxydibutyl ether specifications and serves as a tool for batch-level quality control.
dihydroxydibutyl ether CoA mostly includes findings from lab analyses of a specific batch. For each dihydroxydibutyl ether CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
dihydroxydibutyl ether may be tested according to a variety of international standards, such as European Pharmacopoeia (dihydroxydibutyl ether EP), dihydroxydibutyl ether JP (Japanese Pharmacopeia) and the US Pharmacopoeia (dihydroxydibutyl ether USP).
LOOKING FOR A SUPPLIER?
